BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37564209)

  • 21. High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NFκB Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts.
    Rudisch A; Dewhurst MR; Horga LG; Kramer N; Harrer N; Dong M; van der Kuip H; Wernitznig A; Bernthaler A; Dolznig H; Sommergruber W
    PLoS One; 2015; 10(4):e0124283. PubMed ID: 25919140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NCK1 promotes the angiogenesis of cervical squamous carcinoma via Rac1/PAK1/MMP2 signal pathway.
    Xia P; Huang M; Zhang Y; Xiong X; Yan M; Xiong X; Yu W; Song E
    Gynecol Oncol; 2019 Feb; 152(2):387-395. PubMed ID: 30442385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic implication of MET overexpression in myxofibrosarcomas: an integrative array comparative genomic hybridization, real-time quantitative PCR, immunoblotting, and immunohistochemical analysis.
    Lee JC; Li CF; Fang FM; Wang JW; Jeng YM; Yu SC; Lin YT; Wu JM; Tsai JW; Li SH; Huang HY
    Mod Pathol; 2010 Oct; 23(10):1379-92. PubMed ID: 20639860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent STAT5 phosphorylation and epigenetic dysregulation of GM-CSF and PGS2/COX2 expression in Type 1 diabetic human monocytes.
    Garrigan E; Belkin NS; Alexander JJ; Han Z; Seydel F; Carter J; Atkinson M; Wasserfall C; Clare-Salzler MJ; Amick MA; Litherland SA
    PLoS One; 2013; 8(10):e76919. PubMed ID: 24204704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein kinase D1 (PKD1) phosphorylation on Ser
    Chang JK; Ni Y; Han L; Sinnett-Smith J; Jacamo R; Rey O; Young SH; Rozengurt E
    J Biol Chem; 2017 Jun; 292(23):9523-9539. PubMed ID: 28408623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylation of β-catenin at serine 663 regulates its transcriptional activity.
    Park MH; Kim DJ; You ST; Lee CS; Kim HK; Park SM; Shin EY; Kim EG
    Biochem Biophys Res Commun; 2012 Mar; 419(3):543-9. PubMed ID: 22369945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PAK1 and PAK2 in cell metabolism regulation.
    Kořánová T; Dvořáček L; Grebeňová D; Röselová P; Obr A; Kuželová K
    J Cell Biochem; 2022 Feb; 123(2):375-389. PubMed ID: 34750857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of p21-activated kinase-1 activity with aggressive tumor behavior and poor prognosis of head and neck cancer.
    Park J; Kim JM; Park JK; Huang S; Kwak SY; Ryu KA; Kong G; Park J; Koo BS
    Head Neck; 2015 Jul; 37(7):953-63. PubMed ID: 24634274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P21-activated protein kinase 1 is overexpressed in gastric cancer and induces cancer metastasis.
    Li LH; Luo Q; Zheng MH; Pan C; Wu GY; Lu YZ; Feng B; Chen XH; Liu BY
    Oncol Rep; 2012 May; 27(5):1435-42. PubMed ID: 22293972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pak1 kinase links ErbB2 to β-catenin in transformation of breast epithelial cells.
    Arias-Romero LE; Villamar-Cruz O; Huang M; Hoeflich KP; Chernoff J
    Cancer Res; 2013 Jun; 73(12):3671-82. PubMed ID: 23576562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Rac-Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells.
    Arias-Romero LE; Villamar-Cruz O; Pacheco A; Kosoff R; Huang M; Muthuswamy SK; Chernoff J
    Oncogene; 2010 Oct; 29(43):5839-49. PubMed ID: 20711231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter.
    Latha K; Li M; Chumbalkar V; Gururaj A; Hwang Y; Dakeng S; Sawaya R; Aldape K; Cavenee WK; Bogler O; Furnari FB
    Int J Cancer; 2013 Feb; 132(3):509-20. PubMed ID: 22729867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-stimulated glucose uptake partly relies on p21-activated kinase (PAK)2, but not PAK1, in mouse skeletal muscle.
    Møller LLV; Jaurji M; Kjøbsted R; Joseph GA; Madsen AB; Knudsen JR; Lundsgaard AM; Andersen NR; Schjerling P; Jensen TE; Krauss RS; Richter EA; Sylow L
    J Physiol; 2020 Dec; 598(23):5351-5377. PubMed ID: 32844438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knockdown of PAK1 Inhibits the Proliferation and Invasion of Non-Small Cell Lung Cancer Cells Through the ERK Pathway.
    Wang S; Wang SY; Du F; Han Q; Wang EH; Luo EJ; Liu Y
    Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):602-610. PubMed ID: 31394555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PAK1-Nck regulates cyclin D1 promoter activity in response to prolactin.
    Tao J; Oladimeji P; Rider L; Diakonova M
    Mol Endocrinol; 2011 Sep; 25(9):1565-78. PubMed ID: 21719533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PAK1-mediated MORC2 phosphorylation promotes gastric tumorigenesis.
    Wang G; Song Y; Liu T; Wang C; Zhang Q; Liu F; Cai X; Miao Z; Xu H; Xu H; Cao L; Li F
    Oncotarget; 2015; 6(12):9877-86. PubMed ID: 25888627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus X protein confers resistance of hepatoma cells to anoikis by up-regulating and activating p21-activated kinase 1.
    Xu J; Liu H; Chen L; Wang S; Zhou L; Yun X; Sun L; Wen Y; Gu J
    Gastroenterology; 2012 Jul; 143(1):199-212.e4. PubMed ID: 22484303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of PAK1 gene silencing on proliferation and apoptosis in hepatocellular carcinoma cell lines MHCC97-H and HepG2 and cells in xenograft tumor.
    Zhang ZL; Liu GC; Peng L; Zhang C; Jia YM; Yang WH; Mao L
    Gene Ther; 2018 Jul; 25(4):284-296. PubMed ID: 29802374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolactin-induced PAK1 tyrosyl phosphorylation promotes FAK dephosphorylation, breast cancer cell motility, invasion and metastasis.
    Hammer A; Diakonova M
    BMC Cell Biol; 2016 Aug; 17(1):31. PubMed ID: 27542844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The frequent co-expression of the oncogenes PIK3CA and PAK1 in oral carcinomas.
    Tu HF; Chang KW; Chiang WF; Liu CJ; Yu EH; Liu ST; Lin SC
    Oral Oncol; 2011 Mar; 47(3):211-6. PubMed ID: 21310649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.